argenx to acquire Unnatural Products, adding peptide discovery engine to broaden immunology capabilities
FROM THE WIRE · GLOBENEWSWIRE.COM
Amsterdam, the Netherlands, November 9, 2026, 07:00 CET – argenx (Euronext & Nasdaq: ARGX), the immunology innovation company, today announced a definitive agreement to acquire Unnatural Products, Inc. (UNP), adding a macrocyclic peptide discovery engine to its immunology…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralA mid-sized acquisition by argenx, valued at up to about 1.15 billion dollars.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01argenx will acquire all remaining shares of Unnatural Products.
- 02The transaction values UNP at up to approximately 1.15 billion dollars.
- 03argenx already holds a minority stake in UNP.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets